The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.
Despite a stuffy nose and tightness in his chest, Jason Shaw felt like running. Of course he did. At 39, he'd been exercising nearly every day for more than half his life. He'd run seven marathons. He ...